ursolic acid has been researched along with hymecromone in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
Huang, S; Liu, D; Liu, M; Wu, J; Xia, C; Xie, H; Xiong, Y; Zhang, H | 1 |
Abdul-Al, A; Abildgaard, C; Christensen, A; Christiansen, H; Dahl, C; Filomeni, G; Guldberg, P; Rizza, S; Schmidt, S | 1 |
3 other study(ies) available for ursolic acid and hymecromone
Article | Year |
---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
In vitro inhibition of UGT1A3, UGT1A4 by ursolic acid and oleanolic acid and drug-drug interaction risk prediction.
Topics: Drug Interactions; Glucuronosyltransferase; Hymecromone; Kinetics; Microsomes, Liver; Oleanolic Acid; Protein Isoforms; Triterpenes; Ursolic Acid | 2017 |
Screening of metabolic modulators identifies new strategies to target metabolic reprogramming in melanoma.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Drug Discovery; Glycolysis; Humans; Hymecromone; Melanoma; Mitochondria; Oxidants; Oxidative Stress; Protein Kinase Inhibitors; Small Molecule Libraries; Triterpenes; Ursolic Acid | 2021 |